Nicole R Fram1, Samuel Masket2, Li Wang3. 1. The David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Advanced Vision Care, Los Angeles, California. Electronic address: nicfram@yahoo.com. 2. The David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California; Advanced Vision Care, Los Angeles, California. 3. Baylor College of Medicine, Houston, Texas.
Abstract
PURPOSE: To compare the accuracy of intraoperative aberrometry technology and the Fourier-domain optical coherence tomography (OCT)-based intraocular lens (IOL) formula for IOL power calculation in eyes undergoing cataract surgery after previous laser vision correction (LVC) compared with established methods. DESIGN: Retrospective consecutive case series. PARTICIPANTS: Patients undergoing cataract surgery with a history of LASIK or photorefractive keratectomy. METHODS: The IOL power was estimated preoperatively using the IOLMaster 500 (Carl Zeiss Meditec, Dublin, CA) to calculate the Haigis-L and Masket regression formulae (when prior data were available), and the Optovue RTVue (Optovue Inc, Fremont, CA) spectral domain OCT was used to obtain the Fourier-domain OCT-based IOL formula. The Optiwave Refractive Analysis (ORA) System (WaveTec Vision Systems Inc, Aliso Viejo, CA) wavefront aberrometer measured aphakic refractive measurements intraoperatively and calculated the IOL power with a modified vergence formula. Comparative analysis was done for predictive accuracy of IOL power determination using 2 conventional methods and 2 new technologies: the Haigis-L formula, Masket regression formula, ORA intraoperative aberrometry, and Optovue RTVue Fourier-domain OCT-based IOL formula. Patients without historical data (N = 39) were compared using 3 methods (Haigis-L, ORA, and Optovue), and patients with historical data (N = 20) were compared using all methods (Masket regression formula, Haigis-L, ORA, and Optovue). MAIN OUTCOME MEASURES: Median absolute error (MedAE), mean absolute error (MAE), and percentage of eyes within ±0.25, ±0.50, ±0.75, and ±1.00 diopters (D) of refractive prediction error. RESULTS: A total of 39 eyes of 29 patients without historical data were analyzed separately from 20 eyes of 20 patients with historical data. In the group without historical data (N = 39), 49% of eyes were within ±0.25 D, 69% to 74% of eyes were within ±0.50 D, 87% to 97% of eyes were within ±0.75 D, and 92% to 97% of eyes were within ±1.00 D of targeted refractive IOL power prediction error. The MedAE was 0.26 D for Haigis-L, 0.29 D for ORA, and 0.28 D for Optovue. The MAE was 0.37 D for Haigis-L, 0.34 D for ORA, and 0.39 D for Optovue. In the group with historical data (N = 20), 35% to 70% of eyes were within ±0.25 D, 60% to 85% of eyes were within ±0.50 D, 80% to 95% of eyes were within ±0.75 D, and 90% to 95% of eyes were within ±1.00 D of targeted refractive IOL power prediction error. The MedAE was 0.21 D for the Masket regression formula, 0.22 D for the Haigis-L formula, 0.25 D for ORA, and 0.39 for Optovue. The MAE was 0.28 D for the Masket regression formula, 0.31 D for the Haigis-L formula, 0.37 D for ORA, and 0.44 D for Optovue. There was no statistically significant difference among the methods. CONCLUSIONS: Newer technology to estimate IOL power calculations in eyes after LVC shows promising results when compared with established methods.
PURPOSE: To compare the accuracy of intraoperative aberrometry technology and the Fourier-domain optical coherence tomography (OCT)-based intraocular lens (IOL) formula for IOL power calculation in eyes undergoing cataract surgery after previous laser vision correction (LVC) compared with established methods. DESIGN: Retrospective consecutive case series. PARTICIPANTS: Patients undergoing cataract surgery with a history of LASIK or photorefractive keratectomy. METHODS: The IOL power was estimated preoperatively using the IOLMaster 500 (Carl Zeiss Meditec, Dublin, CA) to calculate the Haigis-L and Masket regression formulae (when prior data were available), and the Optovue RTVue (Optovue Inc, Fremont, CA) spectral domain OCT was used to obtain the Fourier-domain OCT-based IOL formula. The Optiwave Refractive Analysis (ORA) System (WaveTec Vision Systems Inc, Aliso Viejo, CA) wavefront aberrometer measured aphakic refractive measurements intraoperatively and calculated the IOL power with a modified vergence formula. Comparative analysis was done for predictive accuracy of IOL power determination using 2 conventional methods and 2 new technologies: the Haigis-L formula, Masket regression formula, ORA intraoperative aberrometry, and Optovue RTVue Fourier-domain OCT-based IOL formula. Patients without historical data (N = 39) were compared using 3 methods (Haigis-L, ORA, and Optovue), and patients with historical data (N = 20) were compared using all methods (Masket regression formula, Haigis-L, ORA, and Optovue). MAIN OUTCOME MEASURES: Median absolute error (MedAE), mean absolute error (MAE), and percentage of eyes within ±0.25, ±0.50, ±0.75, and ±1.00 diopters (D) of refractive prediction error. RESULTS: A total of 39 eyes of 29 patients without historical data were analyzed separately from 20 eyes of 20 patients with historical data. In the group without historical data (N = 39), 49% of eyes were within ±0.25 D, 69% to 74% of eyes were within ±0.50 D, 87% to 97% of eyes were within ±0.75 D, and 92% to 97% of eyes were within ±1.00 D of targeted refractive IOL power prediction error. The MedAE was 0.26 D for Haigis-L, 0.29 D for ORA, and 0.28 D for Optovue. The MAE was 0.37 D for Haigis-L, 0.34 D for ORA, and 0.39 D for Optovue. In the group with historical data (N = 20), 35% to 70% of eyes were within ±0.25 D, 60% to 85% of eyes were within ±0.50 D, 80% to 95% of eyes were within ±0.75 D, and 90% to 95% of eyes were within ±1.00 D of targeted refractive IOL power prediction error. The MedAE was 0.21 D for the Masket regression formula, 0.22 D for the Haigis-L formula, 0.25 D for ORA, and 0.39 for Optovue. The MAE was 0.28 D for the Masket regression formula, 0.31 D for the Haigis-L formula, 0.37 D for ORA, and 0.44 D for Optovue. There was no statistically significant difference among the methods. CONCLUSIONS: Newer technology to estimate IOL power calculations in eyes after LVC shows promising results when compared with established methods.
Authors: Jack X Ma; Maolong Tang; Li Wang; Mitchell P Weikert; David Huang; Douglas D Koch Journal: Invest Ophthalmol Vis Sci Date: 2016-07-01 Impact factor: 4.799